Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
GPR120 Agonist 5
Cat. No.:
OB0425LY-028
Appearance:
Solid
Purity:
≥95%
Identity:
Confirmed by NMR.
Size:
Add to basket
Product Overview
Description:
GPR120 Agonist 5 is a potent agonist targeting GPR120 that plays an important role in the pathogenesis of obesity, insulin resistance, and type 2 diabetes.
Synonyms:
NCG21; NGC21; 4-{4-[2-(Phenyl-2-pyridinylamino)ethoxy]phenyl}butyric acid; 1079821-35-4; 4-[4-[2-(N-Pyridin-2-ylanilino)ethoxy]phenyl]butanoic acid
CAS No.:
1079821-35-4
Compound CID:
25098573
Formula:
C23H24N2O3
Formula Weight:
376.45
Specification
Target:
Free fatty acid receptor
Pathway:
GPCR/G protein
Storage:
Storage at -20°C.
Applications:
GPR120 Agonist 5 can be used to study mechanisms of obesity, metabolic and inflammatory diseases.
